Who Paid My Doc
Renata Urban
Gynecologic Oncology Seattle, WA Medical Doctor
NPI 1093999740 CMS profile 906802
1959 Ne Pacific St, # 356428 1959 Ne Pacific St 1959 Ne Pacific St, Seattle, WA 98195
General payments
$7,085
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Renata Urban of Seattle, WA is reported in the CMS Open Payments database as having received $7,085 across 7 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 75th percentile of Gynecologic Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $45 | 1 | |
| 2024 | General | $7,040 | 6 |
Beside peers
- Renata Urban
- Gynecologic Oncology median
- Middle half of Gynecologic Oncology
- National median
In program year 2025, general payments to Renata Urban were reported at $45. Among 1,179 Gynecologic Oncology profiles paid that year, the median was $305 and the middle half received between $111 and $1,499.
Show as a table
| Year | Renata Urban | Gynecologic Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $287 | $113–$1,548 | $163 |
| 2020 | $0 | $223 | $59–$2,164 | $114 |
| 2021 | $0 | $193 | $68–$1,139 | $132 |
| 2022 | $0 | $252 | $90–$1,151 | $149 |
| 2023 | $0 | $281 | $102–$1,419 | $160 |
| 2024 | $7,040 | $308 | $108–$1,502 | $164 |
| 2025 | $45 | $305 | $111–$1,499 | $169 |
Breakdown
Billing to Medicare
Part B · data year 2024 · 41 billing codesPaid by Medicare
$43,867
Medicare patients
91
Services billed
294
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 64% | |
| Cancer | 48% | |
| Arthritis | 33% | |
| Depression | 29% | |
| Chronic kidney disease | 24% | |
| Osteoporosis | 24% | |
| Ischemic heart disease | 19% | |
| Atrial fibrillation | 18% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Gynecologic Oncology in Washington
Related records
Gynecologic Oncology in Washington
Practitioners in the same specialty and state, ranked by reported value.
All Gynecologic Oncology
Everyone recorded under this specialty, nationwide.
Doctors in Washington
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.